Hepatitis C vaccine need of the hour

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 7, 2014, Pages 1927-1929

  Verma, Ramesh ^a   Khanna, Pardeep ^a   Chawla, Suraj ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEPATITIS C VACCINE; INTERFERON; PEGINTERFERON; PEPTIDE VACCINE; RECOMBINANT PROTEIN; RIBAVIRIN; TOLL LIKE RECEPTOR 9; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

CELLULAR IMMUNITY; DRUG RESPONSE; GENOTYPE; HEALTH CARE COST; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREVALENCE; VIRUS TRANSMISSION; ANIMAL; CLINICAL TRIAL (TOPIC); DRUG DEVELOPMENT; HEPACIVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE; PRECLINICAL STUDY; PRIMATE; TRENDS;

ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MICE; PRIMATES; VIRAL VACCINES;

EID: 84908363546     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29033     Document Type: Note

References (17)

1. Lerat H, Hollinger FB. Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis 2004; 189:3-6; PMID:14702146; http://dx.doi.org/10.1086/380203
2. Zignego AL, Giannini C, Gragnani L, Piluso A, Fognani E. Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact. J Transl Med 2012; 10:158; PMID:22863056; http://dx.doi.org/10.1186/1479-5876-10-158
3. World Health Organization. Hepatitis C Fact Sheet No.164, July 2013. Available from http://www.who.int/mediacentre/factsheets/fs164/en/
4. World Health Organization, Regional Office for South-East Asia. Viral Hepatitis in the WHO South-East Asia Region, New Delhi; 2011.
5. Uppal Y, Garg S, Malhotra S, Singh MM, Gupta VK, Mishra B, Singh SV. Hepatitis B and C virus infection in an urban slum of Northern India. J Commun Dis 2009; 41:201-4; PMID:22010488
6. Siddiqui FA, Akhtar K, Sherwani RK, Rehman K, Alam F, Ansari A. Prevalence of hepatitis C virus in aligarh: a seven year experience. Indian J Community Med 2009; 34:264-5; PMID:20049311; http://dx.doi.org/10.4103/0970-0218.55299
7. Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007; 13:3730-3; PMID:17659734
8. Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India 2006; 19:203-17; PMID:17100109
9. Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci 2004; 58:255-7; PMID:15226580
10. Sonwane BR, Birare SD, Kulkarni PV. Prevalence of seroreactivity among blood donors in rural population. Indian J Med Sci 2003; 57:405-7; PMID:14515031
11. Proceedings of the International Workshop on Epidemiology, Diagnosis and Management of Hepatitis C Infection. Medicine and the Community. 1996;6(7):1-32.
12. Francis J, et al. Quality forum on hepatitis C virus. Veterans Health System Journal 1998; 96:102
13. Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med 2011; 364:2429-38; PMID:21696309; http://dx.doi.org/10.1056/NEJMcp1006613
14. Fung J, Lai CL, Hung I, Young J, Cheng C, Wong D, Yuen MF. Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. J Infect Dis 2008; 198:808-12; PMID:18657036; http://dx.doi.org/10.1086/591252
15. Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med 2013; 158:329-37; PMID:23460056; http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00005
16. Press Release. (28 November 2013). "Scripps Research Institute Scientists Achieve Most Detailed Picture Ever of Key Part of Hepatitis C Virus". Scripps Research Institute. Retrieved 6 December 2013.
17. Kong L, Giang E, Nieusma T, Kadam RU, Cogburn KE, Hua Y, Dai X, Stanfield RL, Burton DR, Ward AB, et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013; 342:1090-4; PMID:24288331; http://dx.doi.org/10.1126/science.1243876